Characterization of Low-Affinity Binding Sites
for Glibenclamide on the Kir6.2 Subunit
of the -Cell K
ATP
Channel
L. Gros,
1
A. Virsolvy, G. Salazar, D. Bataille, and P. Blache
INSERM U376, CHU Arnaud-de-Villeneuve, 371 rue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
Received February 22, 1999
The ATP-sensitive K
channel, an octameric com-
plex of two structurally unrelated types of subunits,
SUR1 and Kir6.2, plays a central role in the physiolog-
ical regulation of insulin secretion. The sulfonylurea
glibenclamide, which trigger insulin secretion by
blocking the ATP-sensitive K
channel, interacts with
both high and low affinity binding sites present on
-cells. The high affinity binding site has been local-
ized on SUR1 but the molecular nature of the low
affinity site is still uncertain. In this study, we ana-
lyzed the pharmacology of glibenclamide in a trans-
formed COS-7 cell line expressing the rat Kir6.2 cDNA
and compared with that of the MIN6 cell line ex-
pressing natively both the Kir6.2 and the SUR1 sub-
units. Binding studies and Scatchard analysis re-
vealed the presence of a single class of low affinity
binding sites for glibenclamide on the COS/Kir6.2 cells
with characteristics similar to that observed for the
low affinity site of the MIN6 cells. © 1999 Academic Press
K
ATP
channels couple cell metabolism to electrical ac-
tivity in multiple cell types and are important in the
pathophysiology of many tissues (1). In pancreatic cells,
K
ATP
channels link changes in blood glucose concentra-
tion to insulin secretion (2,3). Recent molecular biological
studies have identified the -cell K
ATP
channel and clari-
fied its molecular basis (4). This K
ATP
channel is an
hetero-octameric complex of two structurally unrelated
types of subunits: SUR1 (5), the sulfonylurea-regulated
subunit, a member of the ATP-binding cassette (ABC)
superfamily (6), and Kir6.2, the pore forming subunit,
a member of the inward rectifier potassium channel
family (7,8).
High affinity binding sites for sulfonylureas, bio-
chemically identified in mouse -cells (9) and in several
-cell lines (10,11), have been fully characterized and
finally localized on the SUR1 subunit (5). Pharmaco-
logical and photolabeling studies performed on -cells
were in favor of the presence of a second class of low
affinity binding sites which appear to consist of protein
species different from the high affinity sites, with a
lower molecular weight (12,13). In addition, recent
studies describing an effect of glibenclamide and tolbu-
tamide at high doses on the truncated Kir6.2C26
channel activity (14,15) suggest that interactions of
sulfonylureas with the K
ATP
channel may occur inde-
pendently of SUR1. However, only limited data are
available on the existence and the characteristics of
low-affinity binding sites on the K
ATP
channel.
In this study, we characterized a low affinity binding
site for glibenclamide on MIN6 -cells known to express
the native K
ATP
channel. Furthermore, using primate
COS-7 kidney cells transfected with a chimeric gene con-
taining the cytomegalovirus (CMV) promoter linked to
the rat Kir6.2 cDNA, we demonstrated that kir6.2 subunit
possesses a low affinity binding site for glibenclamide.
MATERIALS AND METHODS
PCR analysis and plasmid construction. Total RNAs from the
RINm5F cell line were treated for 10 min at 37°C with RNase-free
DNase I (BRL). DNase I was inactivate by heating the samples for 10
min at 65°C and first strand cDNAs were synthesized using Superscript
II RNAase H-reverse transcriptase (BRL) with 1 g total RNA primed
by oligo(dT). PCR was performed with Advantage cDNA polymerase
mix (Clontech Laboratories, Inc, Palo Alto, CA). PCR conditions were
94°C, 30 sec, 56°C, 30 sec, 72°C, 1 min, for 40 cycles with 5' AAC GGA
GCC ATG CTG TCC CGA AAG GG 3' and 5' GGG GGC CTG AGG AAC
TGC AAC TCA GG 3' as primer for extension. PCR products were
purified on 1% agarose gel, subcloned with Original TA Cloning Kit
(Invitrogen, San Diego, CA) and sequenced. The resulting coding region
of Kir6.2 was cloned as an EcoRI/EcoRI fragment under the control of
the CMV promoter into the EcoRI site of vector pcDNA3 (Invitrogen) to
generate the pcDNA3/Kir6.2. plasmid.
A 2290 bp fragment of RINm5F SUR1 cDNA was amplified using the
following oligonucleotides: 5'-GAC TCA GAT TGG GGA ACG AGG-3'
and 5'-TGA GGT GTG GGG TGG CAC TTT GGC GCT GG-3'. PCR
conditions were 94°C, 30 sec, 60°C, 30 sec, 68°C, 5 min, for 40 cycles.
PCR product was purified on 1% agarose gel, subcloned with Original
TA Cloning Kit (Invitrogen, San Diego, CA) and sequenced.
1
To whom correspondence should be addressed. Fax: 33 4 67 41 52
22. E-mail: lgros@u376.montp.insem.fr.
Biochemical and Biophysical Research Communications 257, 766 –770 (1999)
Article ID bbrc.1999.0529, available online at http://www.idealibrary.com on
766 0006-291X/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.